[Federal Register Volume 69, Number 18 (Wednesday, January 28, 2004)]
[Notices]
[Pages 4185-4186]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E4-131]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI). The 
agenda is under development, but will relate to issues arising from the 
revised 10 CFR part 35, Medical Use of Byproduct Material. To review 
agenda items as they become available, see http://www.nrc.gov/reading-rm/doc-collections/ acmui/schedules/2004/ or contact[email protected].

DATES: ACMUI will hold a public meeting on March 1, 2004, from 8 a.m. 
to 5 p.m. On March 2, the ACMUI will convene at 8 a.m. for its public 
meeting, but will brief the Commission from 9:30 a.m.-12 p.m. At 1 p.m. 
on March 2, the ACMUI will recconvene, if necessary, to continue its 
public meeting until 5 p.m. The meeting and the Commission briefing 
will take place at the addresses provided below.

ADDRESSES: For Commission Briefing: U.S. Nuclear Regulatory Commission, 
One White Flint North Building, Commissioners' Conference Room 1G16, 
11555 Rockville Pike, Rockville, MD, 20852-2738.
    For Public Meeting: U.S. Nuclear Regulatory Commission, Two White 
Flint North Building, Auditorium, 11545 Rockville Pike, Rockville, MD 
20852-2738.

FOR FURTHER INFORMATION CONTACT: Angela R. Williamson, telephone (301) 
415-5030; e-mail [email protected] of the Office of Nuclear Material Safety 
and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001.

Conduct of the Meeting

    Manuel D. Cerqueira, M.D., will chair the meeting. Dr. Cerqueira 
will conduct

[[Page 4186]]

the meeting in a manner that will facilitate the orderly conduct of 
business. The following procedures apply to public participation in the 
meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Angela R. Williamson, U.S. Nuclear Regulatory 
Commission, Two White Flint North, Mail Stop T8F5, 11545 Rockville 
Pike, Rockville, MD 20852-2738. Submittals must be postmarked by 
February 9, 2004, and must pertain to the topics on the agenda for the 
meeting.
    2. Questions from members of the public will be permitted during 
the meeting, at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection on NRC's Web site (www.nrc.gov) and at the NRC Public 
Document Room, 11555 Rockville Pike, Rockville, MD 20852-2738, 
telephone (800) 397-4209, on or about March 22, 2004. Minutes of the 
meeting will be available on or about May 3, 2004.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: January 23, 2004.
Andrew L. Bates,
Advisory Committee Management Officer.
 [FR Doc. E4-131 Filed 1-27-04; 8:45 am]
BILLING CODE 7590-01-P